CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
USD |
NASDAQ |
Mar 21, 16:00
CymaBay Therapeutics Enterprise Value: 3.443B for March 25, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Gilead Sciences, Inc. | 169.61B |
| Assure Holdings Corp. | -- |
| Societal CDMO Inc (DELISTED) | 145.26M |
| AN2 Therapeutics, Inc. | -26.02M |
| Madrigal Pharmaceuticals, Inc. | 10.71B |
Enterprise Value Related Metrics
| Profit Margin (Quarterly) | -73.51K% |
| Earnings Yield | -3.05% |
| Normalized Earnings Yield | -3.048 |